Dr. Manfred Ziegler Joins Flora Growth Corp. as Managing Director, Bolstering German Business with Unmatched Expertise

Core Insights - Flora Growth Corp. has appointed Dr. Manfred Ziegler as Managing Director, enhancing its leadership in the German cannabis market [2][3] - Dr. Ziegler's extensive experience in the pharmaceutical industry, particularly his role in the sale of CC Pharma to Tilray, positions him as a key asset for Flora's growth strategy in Europe [4][5][6] Company Strategy - The appointment of Dr. Ziegler is aimed at accelerating Flora's ambition to become a leading cannabis company in Germany, focusing on increasing market share and establishing a strong presence in the European cannabis sector [3][8] - Dr. Ziegler will lead initiatives including the launch of a parallel import business in Germany, which involves importing pharmaceutical products from lower-priced EU countries to enhance competitiveness [9] Leadership Background - Dr. Ziegler has over 30 years of experience in the pharmaceutical and healthcare sectors, recognized for his expertise in corporate restructuring and business transformation [6] - His previous leadership at CC Pharma resulted in significant growth and innovation, making it one of Europe's leading pharmaceutical distributors [4][6] Market Positioning - The sale of CC Pharma to Tilray was a pivotal transaction that positioned Tilray as a major player in the European medical cannabis market, leveraging CC Pharma's distribution network [5] - Flora Growth aims to utilize Dr. Ziegler's insights on international distribution strategies and regulatory compliance to enhance its operations in Europe [8]